<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="136091">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01807780</url>
  </required_header>
  <id_info>
    <org_study_id>01/2011 UGSAN</org_study_id>
    <nct_id>NCT01807780</nct_id>
  </id_info>
  <brief_title>Safety, Immunogenicity And Efficacy Of Vaccination In Military Personnel</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <authority>Italy: Ethical Comittee</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if multiple vaccination in military personnel may
      be correlated with the appearance of poorly defined diseases as symptomatic multisyndrome,
      autoimmune or lymphoproliferative disorders. At the same time, considering possible
      interference between different vaccines, proteins and polysaccharides, living and
      inactivated, the study aims to assess the immunogenicity and efficacy also in relation to
      the specific Human Leucocyte Antigens (HLA) genetic structure.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>immunomediated disorders related to multiple vaccination</measure>
    <time_frame>three years</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>immunogenicity of multiple vaccination</measure>
    <time_frame>Three years</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>efficacy of multiple vaccination</measure>
    <time_frame>Three years</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <condition>Vaccination Adverse Events</condition>
  <condition>Vaccination Efficacy</condition>
  <condition>Vaccination Immunogenicity</condition>
  <arm_group>
    <arm_group_label>single arm  :vaccinated</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>military personnel vaccinated with multiple vaccines and monitored about safety, immunogenicity and efficacy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>biological monitoring</intervention_name>
    <arm_group_label>single arm  :vaccinated</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Military volunteers

          -  No recently immunized

        Exclusion Criteria:

          -  Pregnancy

          -  Documented immunodepression

          -  Documented allergy or hypersensitivity to vaccines
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Roma La Sapienza</name>
      <address>
        <city>Roma</city>
        <state>Italia</state>
        <zip>00185</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raffaele D'Amelio</last_name>
      <phone>0633775375</phone>
      <email>raffaele.damelio@uniroma1.it</email>
    </contact>
    <investigator>
      <last_name>Raffaele D'Amelio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 6, 2013</lastchanged_date>
  <firstreceived_date>December 13, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Roma La Sapienza</investigator_affiliation>
    <investigator_full_name>Raffaele D'Amelio</investigator_full_name>
    <investigator_title>Full Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
